HAMPTON, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced ...
Conference Call and Webcast at 8:30am Eastern Time Today VBL is well capitalized, cash ...
-- First quarter 2017 EXONDYS 51® (eteplirsen) total net revenues of $64.6 million -- ...
